Dr. Melinda Cail from Primary Health Partners joins us in the KFOR Studios on Thursday afternoon to discuss Parkinson's disease.

The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and ...

Neu Health, a newly released phone app cleared by the FDA this week could help measure early, tell-tale signs of a growing ...

It was the early 2000s when researchers first showed that exercise can help relieve the tremors that are common with ...

The researchers identified specific compounds inside earwax. The work builds on earlier findings suggesting that Parkinson's ...

Long-term cycling programs appear to reshape brain signals in Parkinson’s patients Deep brain stimulation recordings reveal ...

Detecting early rising Parkinson's disease (PD) symptoms could improve treatment outcomes by enabling earlier treatment ...

Osbourne was impacted by a gene called PARK 2, which is also known as PRKN-2. When the gene is mutated, it is the most common ...

Heavy metal rocker Ozzy Osbourne died July 22 at the age of 76, just weeks after his farewell show and about five years after ...

UW-Eau Claire students are developing gloves that could help reduce symptoms of Parkinson's disease, and now they have ...

An early-stage clinical trial in France appeared to help restore some brain function for three Parkinson's patients. View on ...

Detecting early rising Parkinson's disease (PD) symptoms could improve treatment outcomes by enabling earlier treatment ...